SEATTLE, WA USA — Glencoe Software Inc., a world-leader in image data management platforms for the research, biopharma and publication industries, is pleased to announce the completion of its Seed Investment Round, in partnership with TAGS (TIE Angels Group Seattle), several Seattle area angel investors, and Glencoe Friends and Family. This Seed Round has raised […]
SUNNYVALE, Calif.– Cepheid (Nasdaq: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) for expanded claims on its Xpert® MTB/RIF test. Xpert MTB/RIF detects Mycobacterium tuberculosis complex (MTB-complex) DNA and in positive specimens, provides simultaneous identification of rifampin-resistance associated mutations of the rpoBgene. The expanded product claim enables clinicians […]
HILDEN, Germany, and BEIJING, China -– Groundbreaking clinical data published today in the The Lancet medical journal showed that reliance on the 100-year-old tuberculin skin test has significantly overestimated latent tuberculosis infections in China, while results in the same patients using the QuantiFERON-TB Gold (QFT®) from QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) provided […]
NEW YORK, NY — Enzo Biochem, Inc. (NYSE: ENZ) today announced the development of a new novel platform with consequential and broad application for detection of genotypic and phenotypic markers via flow cytometry, as well as the first product for its use addressing the cervical cancer testing market. The platform, FlowScript™, allows for the multiplex […]
Sunnyvale, California ?? Labcyte, a company revolutionizing life science research with its patented acoustic liquid handling technology, today praised the results of an international collaboration between the Institute for Molecular Medicine Finland (FIMM), University of Helsinki and the pharmaceutical company Pfizer. The research, described on 9 February, 2015, in the journal Nature1, identified a previously […]
Sunnyvale, California ?? Labcyte, a company revolutionizing life science research with its patented acoustic liquid handling technology, today praised the results of an international collaboration between the Institute for Molecular Medicine Finland (FIMM), University of Helsinki and the pharmaceutical company Pfizer. The research, described on 9 February, 2015, in the journal Nature1, identified a previously […]
Pleasanton — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Signature Diagnostics AG (Signature), a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical […]
MENLO PARK, Calif. — Asterias Biotherapeutics, Inc. (NYSE MKT: AST) (the “Company”), a leading biotechnology company in the emerging field of regenerative medicine, today announced today that it has priced an underwritten public offering of its common stock at a price of $3.90 per share. Concurrently, the Company entered into a private placement for the […]
Pittsfield, MA – Nuclea Biotechnologies, Inc. announced today that it is partnering with BacterioScanTM INC. (St. Louis, Missouri )in validation of their BacterioScan 216Dx instrument in a CLIA certified laboratory. This collaboration will focus on antimicrobial susceptibility testing (AST) to guide the best course of antibiotic treatment for different strains of urinary tract infections. BacterioScanTM […]
CARLSBAD, Calif.– Thomas Jefferson University (TJU), the Institute Pasteur, the Organization of International Visitors of the USA (OIV-USA) and Thermo Fisher Scientific today announced they have formed a collaborative training program designed to preemptively combat the potential threat of an Ebola virus epidemic in Ivory Coast. The partnership includes training of a visiting scientist who […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
